Inclusive, innovative park opens for Houstonians of all abilities

park for all

James Driver Park is the city's first all-inclusive space. Photo courtesy of Harris County Precinct 2

In a city lush with greenspace, Houston is about to debut a first. James Driver Inclusive Park, when it opens on Saturday, December 11, will be the first community park created specifically for visitors of every experience, ability, and special need on the spectrum.

Attendees can join the ribbon cutting and grand opening ceremony that starts at noon at the park in Aldine (10918 Bentley St.); Harris County Precinct 2 Commissioner Adrian Garcia will lead the ceremonies.

“James Driver Inclusive Park will be the flagship park for Precinct 2 and all of Harris County,” Garcia tells CultureMap. “I expect it to transform how we all think about community spaces and inclusivity. Approximately half a million residents of Harris County live with some sort of physical or cognitive disability, yet, somehow, this park is the first of its kind in Harris County. James Driver Park will be a game-changer for so many families who have children with mobility or sensory issues or even parents who are in wheelchairs.”

Key park amenities include:

  • An improved and widened walking trail that will accommodate two people in wheelchairs, side by side
  • A playground featuring specially designed, wheelchair-friendly equipment where kids can spin, sway, swing, slide and splash
  • An outdoor gaming and fitness area featuring bocce, shuffleboard, chess tables, corn hole, bean bag toss and fitness equipment
  • A misting area and plenty of shade, providing relief from the heat
  • A remodeled and expanded community center, open in back to reveal lush green space
  • A covered dining space and outdoor picnic areas
  • A sensory garden featuring indigenous perennials
  • An event lawn and pavilion for musical and other entertainment
  • An art wall for installations of art by local artists
  • A cistern that will capture rainwater for water play and irrigationA METRO bus stop and plenty of parking
  • A designated parking area for taco and other food trucks

Parents and families can look for these key features for those with special needs, per press materials:

Big bridge
The bridge’s design allows for self-regulated play experiences for children of all ages and abilities to exercise risk, failure, and mastery. An extra-wide ramp and bridge (8 feet) allows for people in wheelchairs and/or mobility devices to easily pass side by side barrier free.

Three play towers offer graduated challenges for climbing, sliding, and balancing, while the overall 80-foot long structure offers areas of respite for all ages and abilities to enjoy the park from above.

Shoulder wheel and serpentine path
These two peripheral elements are designed for older adults or persons with mobility challenges to exercise independently. The shoulder wheel is designed specifically to increase shoulder mobility; the serpentine path uses hand/eye coordination to strengthen small motor skills.

Sensory garden
Studies show the greener the play area, the better the concentration and mental function. The sensory garden utilizes a crazy maze, rolling bells, and serpentine path to foster motor skills and hand eye coordination.

A key element is the ability here to easily withdraw from the active play area but still feel incorporated in the activity as an onlooker for those who may get overwhelmed easily. The sensory garden also appeals to at least one of the five senses; sight, smell, sound, taste, and touch.

For those not local, Garcia notes that the greenspace is well worth the drive for its inclusivity, tangible benefits, and its ability to create a joyful, all encompassing experience. “This park allows families to all play together,” he adds.

------

This article originally ran on CultureMap.

A program at UH has just gotten a rare and prestigious accreditation. Photo by Tom Fisk from Pexels

University of Houston logistics and transportation program receives global accreditation

leveled up

A program at the University of Houston has received a rare global accreditation that will allow for more opportunities for the students in both the graduate and undergraduate programs.

The Chartered Institute of Logistics and Transport has accredited UH's Supply Chain & Logistics Technology bachelor's and master's degree plans. Now, students can apply for membership upon graduation and use the CILT credential after their name, according to a press release from UH, and this is the first academic program in the United States to have this distinction.

"In launching our globally-recognized credential program, we are addressing gaps in skill sets and focusing on filling those gaps with our students, helping them become more marketable," says Margaret Kidd, program director of Supply Chain & Logistics Technology, in the release.

Port Houston has granted $50,000 to the program, and these funds are being used to take the curriculum digital and allow for an online platform for certificate courses.

"The College of Technology prides itself in providing degree programs that support the workforce – a workforce that both needs to expand in numbers to boost the economy, but also to provide a more relevant education for industry and commerce," says Anthony P. Ambler, dean of the UH College of Technology, in the release. "We are grateful to the Port Houston and its support of our technology program which explicitly exposes students to how business operates so that they are able to be productive quickly."

The news was announced at a press conference at UH. Harris County Commissioner for Precinct 2 Adrian Garcia and Port Houston Commissioner Wendy Montoya Cloonan joined UH representatives at the event.

"The pandemic has wrecked several sectors of the economy, directly impacting thousands, and so many are searching for new skills that translate to this new normal. This UH program, funded by Port grants, is yet another way we and our partners are addressing that," says Commissioner Garcia. "Hardworking people need locally elected officials, educational institutions, and industry to help us get past these difficult times, which is why I am extremely excited about the launch of this program."

The first group of participants for the program will come from dual-credit high schools with a logistics focus and community colleges offering logistics and international business degrees.

"Our program plays an integral part in preparing the next generation of workers. We thank Port Houston for funding our project which provides meaningful influence for area students," says Kidd.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston biotech startup secures $10M seed round to propel cancer-fighting therapy from bench to bedside

fresh funding

A Houston biotech company based off research out of UTHealth Houston has raised seed funding to continue developing its cancer-fighting therapeutic.

CrossBridge Bio, formed during the TMC Innovation’s Accelerator for Cancer Therapeutics program, closed a $10 million seed round led by TMC Venture Fund and Crescent Enterprises' VC arm, CE-Ventures. The round also included participation from Portal Innovations, Alexandria Venture Investments, Linden Lake Labs, and several pre-seed investors.

“We are thrilled to have the support of such experienced investors who share our vision of bringing transformative cancer therapies to patients in need,” Michael Torres, CEO of CrossBridge Bio, says in a news release. Torres served as an entrepreneur in residence of ACT.

The company is working on the next-generation of antibody-drug conjugates (ADC) therapeutics that process dual payloads as targeted treatments for a set of challenging cancers. The innovative treatment is based on research from UTHealth experts Dr. Kyoji Tsuchikama and Dr. Zhiqiang An.

“Our dual-payload ADC technology is designed to deliver synergistic therapeutic effects using highly stable linkers that ensure payload release only within the targeted cancer cells, thereby maximizing their therapeutic effectiveness while minimizing the liabilities associated with uptake in unintended tissues, as seen with many of today’s cancer treatments," Torres continues.

He explains that the funding will toward advancing CrossBridge's first development candidate, CBB-120, into preclinical non-GLP toxicology studies in addition to derisking the company’s proprietary linker technology with dual-payload applications, per the release.

As a result of the raise, William McKeon, president and CEO of the Texas Medical Center, and Damir Illich, manager of life sciences of CE-Ventures, will join CrossBridge Bio’s board of directors.

“We are proud to back CrossBridge Bio in their mission to develop the next generation of cancer therapies,” McKeon says in the release. “Their dual-payload ADCs are designed to deliver targeted drug release within cancer cells with greater stability, precision, and control. These breakthrough advancements have the potential to change patients’ lives worldwide and we look forward to helping drive their development.”

Houston firm scores 2 grants to support testing treatment for addiction, neurodegenerative diseases

money moves

A Houston organization devoted to developing early-stage therapeutic and medical device technologies announced fresh funding for one of its startups.

Fannin Partners' Goldenrod Therapeutics, received a $320,000 Phase I SBIR grant from the National Institute on Drug Abuse (NIDA) for studies regarding both addiction medicine and neurodegenerative diseases with a single lead candidate, called 11h.

The grant will fund studies in rodent models of methamphetamine addiction and the efficacy of 11h for the tiny patients. This is the next step in charting the established promise of 11h in substance use disorders using animal models. Existing therapies for opioid and alcohol addiction have high relapse rates, and there are currently no FDA-approved medications for Stimulant Use Disorders (StUDs).

Previous preclinical studies demonstrated that 11h was effective in the fight against cocaine addiction. The goal is to note similar results in methamphetamine addiction.

At the same time, Fannin was also granted a $250,000 Early Hypothesis Development Award from the Department of Defense (DoD) to study 11h in neurodegenerative diseases. Specifically, the funds will be used to work on rodent models of multiple sclerosis (MS).

Fannin’s goal is to develop an oral medication that slows or reverses the progression of MS, while also improving the patient’s quality of life by relieving symptoms. Many MS medications come with the threat of liver injury and increased risk of infection, so sidestepping those is also a hope for 11h.

In fact, 11h was developed to minimize the toxicities associated with existing PDE4 inhibitors. Early evidence shows that the drug is not only effective, but also safe and easily tolerable.

“NIDA’s continued support of our SUD program highlights the potential of 11h to significantly improve the standard of care for patients suffering from these conditions, some of which lack any approved pharmaceutical options," says Dr. Atul Varadhachary, managing partner at Fannin, in a news release. “The additional DoD funding will allow us to explore 11h’s impact on neurodegenerative disease, as well. We are grateful for the support from both organizations as we advance 11h towards clinical development.”

Previous steps in 11h’s development were funded by a $350,000 Phase I SBIR grant from NIDA. 11h is part of NIDA’s Addiction Treatment Discovery Program. Next year, Fannin will likely scale up Good Manufacturing Practices (GMP) production and complete toxicology studies. This will lead to clinical trials for 11h for cocaine use disorder and other StUDs. But don’t expect Fannin to be quiet for long. Its next big discovery is always on the horizon.

Autonomous truck company taps breaks on Houston-Dallas route

re-routing

Autonomous truck company Aurora Innovation says it won't start hauling freight without humans on board until April of next year, a delay from previous statements that commercial service would begin by the end of 2024.

The Pittsburgh company on Wednesday said the April launch of driverless semis traveling from Dallas to Houston — originally announced last year — will be “modestly later” than the company had intended. The company also previously announced a partnership with Uber.

The company told investors on its third-quarter earnings conference call that it has made progress toward ensuring its trucks will operate safely.

Remaining obstacles are “primarily in the areas of some elements of surface street driving and some elements of construction that we see on the freeway,” CEO Chris Urmson said. “We want to have extremely high confidence in the system as we as we go forward.”

The company will start with about 10 autonomous tractor-trailers and move to “tens” of trucks by the end of next year, Urmson said.

“This shift to our timeline will have a negligible financial impact and does not affect our scaling efforts on our path to self-funding," Urmson said.

Aurora also intends to haul freight without human drivers from Fort Worth, Texas, to Phoenix later in 2025, Urmson said.

Aurora in August added nearly $500 million to its balance sheet with a capital raise in August, which the company expects to fund the initial phases of its strategy to scale up driverless trucking.

View All Listings